Convertible Note Progress Brings Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Closer to Commercialization of New Surgical Tech
Imagin Medical Inc. announced that it has now raised $2.165 million of the recent its convertible note offering The closing of the latest funding tranche will support the company’s progress toward the commercialization of its revolutionary bladder cancer visualization technology once final FDA approval is granted With better viewing options, the technology is designed to make it easier for surgeons to detect the full parameters of bladder tumors and remove them more completely Bladder cancer is one of the most prevalent cancers in the United States, particularly in men The technological improvement of these surgical procedures can provide an attractive…